Is ionic choline and geranate (CAGE) liquid caging diet-derived fat, limiting its absorption?
作者信息
Peiretti Franck, Valéro René, Govers Roland
机构信息
Aix Marseille University, INSERM, INRAE, C2VN (Centre de Recherche en CardioVasculaire et Nutrition), 13385, Marseille, France.
Aix Marseille University, APHM, INSERM, INRAE, C2VN, University Hospital La Conception, Department of Nutrition, Metabolic Diseases and Endocrinology, 13005, Marseille, France.
出版信息
Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8247-8248. doi: 10.1073/pnas.2000032117. Epub 2020 Mar 17.
Abstract
摘要
相似文献
1
Is ionic choline and geranate (CAGE) liquid caging diet-derived fat, limiting its absorption?离子型胆碱和香叶酸盐（CAGE）液体笼养饮食衍生的脂肪是否会限制其吸收？
Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8247-8248. doi: 10.1073/pnas.2000032117. Epub 2020 Mar 17.
2
The molecular mechanism behind the stabilization of insulin by choline and geranate (CAGE) ionic liquids - computational insights into oral insulin drug formulation.胆碱和格尔酸（CAGE）离子液体稳定胰岛素的分子机制 - 口服胰岛素药物制剂的计算见解。
Phys Chem Chem Phys. 2021 Nov 17;23(44):25298-25307. doi: 10.1039/d1cp03349b.
3
Oral ionic liquid for the treatment of diet-induced obesity.口服离子液体治疗饮食诱导的肥胖。
Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25042-25047. doi: 10.1073/pnas.1914426116. Epub 2019 Nov 25.
4
Is "choline and geranate" an ionic liquid or deep eutectic solvent system?“胆碱与香叶酸盐”是离子液体还是低共熔溶剂体系？
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E10999. doi: 10.1073/pnas.1814976115. Epub 2018 Nov 6.
5
Mucoadhesive Ionic Liquid Gel Patches for Oral Delivery.用于口服给药的粘膜粘附型离子液体凝胶贴片
ACS Biomater Sci Eng. 2023 Jun 12;9(6):2838-2845. doi: 10.1021/acsbiomaterials.0c01024. Epub 2020 Sep 3.
6
Choline geranate (CAGE): A multifaceted ionic liquid for drug delivery.胆碱生育酚酯（CAGE）：一种用于药物传递的多面离子液体。
J Control Release. 2024 Dec;376:593-600. doi: 10.1016/j.jconrel.2024.10.034. Epub 2024 Oct 25.
7
Counteractive Effects of Choline Geranate (CAGE) ILs and Ethanol on Insulin's Stability-A Leap Forward towards Oral Insulin Formulation.胆碱石榴酸盐（CAGE）离子液体和乙醇对胰岛素稳定性的拮抗作用——口服胰岛素制剂的新突破。
Molecules. 2022 Aug 8;27(15):5031. doi: 10.3390/molecules27155031.
8
Newly isolated lytic bacteriophages for Staphylococcus intermedius, structurally and functionally stabilized in a hydroxyethylcellulose gel containing choline geranate: Potential for transdermal permeation in veterinary phage therapy.用于中间葡萄球菌的新型分离裂解噬菌体，在含有胆甾醇香叶酯的羟乙基纤维素凝胶中结构和功能稳定：兽医噬菌体治疗中经皮渗透的潜力。
Res Vet Sci. 2021 Mar;135:42-58. doi: 10.1016/j.rvsc.2020.12.013. Epub 2020 Dec 24.
9
Oral delivery of sorafenib through spontaneous formation of ionic liquid nanocomplexes.通过自发形成的离子液体纳米复合物实现索拉非尼的口服递送。
J Control Release. 2020 Jun 10;322:602-609. doi: 10.1016/j.jconrel.2020.03.018. Epub 2020 Mar 19.
10
The Influence of Water on Choline-Based Ionic Liquids.水对胆碱基离子液体的影响。
ACS Biomater Sci Eng. 2019 Jul 8;5(7):3645-3653. doi: 10.1021/acsbiomaterials.9b00243. Epub 2019 May 31.
引用本文的文献
1
Reply to Peiretti et al.: Effect of CAGE on fat uptake and food intake.对佩雷蒂等人的回复：CAGE对脂肪摄取和食物摄入的影响。
Proc Natl Acad Sci U S A. 2020 Apr 14;117(15):8249. doi: 10.1073/pnas.2001030117. Epub 2020 Mar 17.
本文引用的文献
1
Oral ionic liquid for the treatment of diet-induced obesity.口服离子液体治疗饮食诱导的肥胖。
Proc Natl Acad Sci U S A. 2019 Dec 10;116(50):25042-25047. doi: 10.1073/pnas.1914426116. Epub 2019 Nov 25.
2
Studies of indirect and direct effects of hypervitaminosis A on rat bone by comparing free access to food and pair-feeding.通过比较自由进食和配对进食研究维生素 A 过量对大鼠骨的间接和直接影响。
Ups J Med Sci. 2018 Jun;123(2):82-85. doi: 10.1080/03009734.2018.1448020. Epub 2018 Apr 26.
3
Pair Feeding, but Not Insulin, Phloridzin, or Rosiglitazone Treatment, Curtails Markers of β-Cell Dedifferentiation in Mice.配对喂养而非胰岛素、根皮苷或罗格列酮治疗可减少小鼠β细胞去分化标志物。
Diabetes. 2017 Aug;66(8):2092-2101. doi: 10.2337/db16-1213. Epub 2017 May 15.
4
Bariatric surgery for obesity and metabolic disorders: state of the art.肥胖和代谢紊乱的减重手术：最新技术。
Nat Rev Gastroenterol Hepatol. 2017 Mar;14(3):160-169. doi: 10.1038/nrgastro.2016.170. Epub 2016 Nov 30.
5
Safety and tolerability review of lorcaserin in clinical trials.氯卡色林在临床试验中的安全性和耐受性评估
Clin Obes. 2016 Oct;6(5):285-95. doi: 10.1111/cob.12159.
6
Benefit-risk assessment of orlistat in the treatment of obesity.奥利司他治疗肥胖症的获益-风险评估。
Drug Saf. 2014 Aug;37(8):597-608. doi: 10.1007/s40264-014-0210-7.
7
Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn rats.奥利司他治疗可增加高胆红素血症Gunn大鼠的粪便胆红素排泄并降低血浆胆红素浓度。
J Pediatr. 2003 Sep;143(3):327-34. doi: 10.1067/s0022-3476(03)00298-1.
8
Effects of pair-feeding and growth hormone treatment on obese transgenic rats.
Eur J Endocrinol. 2002 Feb;146(2):245-9. doi: 10.1530/eje.0.1460245.
Zotero 插件